111 Revenue 2011-2025 | YI

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.^[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue 111

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	12.4 B	8.2 B	3.95 B	1.79 B	959 M	874 M	-	-	-	-	-

All numbers in CNY currency

Indicator range from annual reports

Maximum	Minimum	Average
12.4 B	874 M	4.7 B

References

Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Pharmaceutical retailers industry

Issuer	Revenue	Price	% 24h	Market Cap	Country
Аптеки 36.6 APTK	39.3 B	-	-	-	Russia
China Jo-Jo Drugstores, Inc. CJJD	117 M	-	-5.59 %	$ 49.9 M	China
Greenlane Holdings GNLN	137 M	$ 2.99	-3.24 %	$ 22.5 M	USA
BOQI International Medical BIMI	11.8 M	-	6.33 %	$ 5.86 M	China
Trxade Group MEDS	8.27 M	-	4.55 %	$ 5.8 M	USA
PetMed Express PETS	227 M	$ 3.02	70.69 %	$ 62.2 M	USA
LifeMD LFMD	153 M	$ 3.45	-4.43 %	$ 117 M	USA
Rite Aid Corporation RAD	24.1 B	-	-	$ 35.5 M	USA
Walgreens Boots Alliance WBA	148 B	-	-	$ 10.3 B	USA